CONMED Corp (CNMD) Stock
1 member of Congress disclosed 2 trades in CNMD since 2019: 1 purchase and 1 sale, most recently Nicholas Van Taylor (sale, Mar 25, 2019). 5 of the hedge funds AlphaScala tracks reported CNMD in 13F filings for the quarter ended Jun 30, 2026; the largest reported position is Marshall Wace's at $5.74M.
Which members of Congress traded CONMED Corp (CNMD)?
Most recent: Nicholas Van Taylor (sale, Mar 25, 2019); records start Feb 15, 2019.
| Politician | Trade date | Type | Amount |
|---|---|---|---|
| Van Taylor R-TX · House | 2019-03-25 | sale | $1k – $15k |
| Van Taylor R-TX · House | 2019-02-15 | purchase | $1k – $15k |
From STOCK Act periodic transaction reports. House filings as of Oct 20, 2026.
See all CNMD political trades →Which hedge funds own CNMD?
From 13F filings| Fund | Shares Held | Position Value | Change vs prior Q |
|---|---|---|---|
| Marshall Wace | 175K | $5.74M | +3% |
| Citadel Ken Griffin | 142K | $4.66M | -42% |
| Millennium Management Israel Englander | 115K | $3.75M | +51% |
| Point72 Steve Cohen | 70K | $2.28M | -48% |
| D.E. Shaw David Shaw | 68K | $2.23M | +42% |
13F holdings as of Jun 30, 2026
Explore all tracked funds →CNMD price chart
Powered by TradingViewWhat does CONMED Corp do?
CONMED Corporation is a global medical technology company that designs, manufactures, and distributes surgical equipment and medical devices for orthopedic and general surgery specialties. The company's orthopedic surgery segment provides products for soft tissue repair, powered resection instruments, and foot and ankle surgery systems. Its general surgery division offers advanced surgical and endoscopic technologies, including the AirSeal insufflation system for minimally invasive procedures, smoke evacuation products, electrosurgical generators, and specialized devices for gastroenterology and pulmonology procedures. CONMED serves healthcare professionals including surgeons and specialists in orthopedics, general surgery, gynecology, thoracic surgery, and related fields across approximately 100 countries. The company operates through sales subsidiaries and distribution networks in major markets including the United States, Europe, Asia Pacific, and other regions. CONMED caters to various healthcare settings ranging from ambulatory surgery centers and endoscopy suites to large hospital systems, focusing on delivering solutions that enhance surgical efficiency and patient outcomes in value-based care environments.